Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nicotine metabolite shows promise for improving memory, protecting brain cells

12.11.2003


Dr. Jerry J. Buccafusco presents his findings about the benefits of the nicotine metabolite cotinine at the November meeting of the Society for Neuroscience.


A nicotine metabolite shows promise for improving memory and protecting brain cells from diseases such as Alzheimer’s and Parkinson’s without addiction and other side effects of nicotine, says a Medical College of Georgia researcher.

Laboratory studies also indicate the metabolite cotinine may be a safe treatment for the debilitating psychotic behavior of schizophrenics, Dr. Jerry J. Buccafusco, pharmacologist and director of the MCG Alzheimer’s Research Center, says in an abstract presented at the 33rd Annual Meeting of the Society for Neuroscience in New Orleans, Nov. 8-12.

"Many people have thought the drug was an essentially inactive metabolite, but we have shown that at appropriate doses, it is memory enhancing, neuro-protective and it has antipsychotic activities," says Dr. Buccafusco, who is also a research pharmacologist at the Department of Veterans Affairs Medical Center in Augusta.



"We hope this new appreciation for cotinine’s potential will encourage people to take a look at cotinine and, if not the drug itself, maybe design newer compounds based on cotinine’s structure that have fewer side effects than existing therapies," he says, noting the need to expand laboratory studies before any clinical work can begin.

"In the case of Alzheimer’s, cotinine may share nicotine’s ability to improve attention and memory and at the same time reduce or halt disease progression. One advantage of cotinine is that it could be used long-term with little concern about serious side effects and substance abuse," Dr. Buccafusco says.

Cotinine stays in the body much longer than short-acting nicotine but appears much safer than its parent alkaloid, which is highly addictive and causes blood vessel constriction, nausea and stomach cramps. Cotinine’s biggest use has been as a marker for tobacco use by measuring urine levels; its therapeutic potential in curbing smoking also has been explored.

"So cotinine has been taken by humans as a drug and has gotten mixed reviews in the literature about its effectiveness," says Dr. Buccafusco, who got interested in the metabolite after noting that the memory-enhancing benefit of nicotine lasted long after the drug was eliminated from the body. Nicotine has a half-life in the body of about an hour, yet he noted in studies that the monkeys continued to derive memory benefits long after the nicotine had left the body.

To explore that potential, he used a computer-assisted matching game where monkeys first pick one of three colors on a screen and get a food reward for picking the same color from a choice of two a few moments later. Both young and old monkeys that received cotinine got more correct answers than the ones that didn’t; results were similar to those Dr. Buccafusco has found with nicotine.

Studying cotinine’s effect on neuron-like cells in culture, he was surprised to find cotinine was also as effective as nicotine at preventing cell death. In this model, he took growth factor away from the cells, so they start to die as they do in neurodegenerative diseases such as Alzheimer’s. "If you put nicotine in there, either before or at the time you take away growth factors, it totally prevents the cells from dying. When we tried cotinine in that assay, it worked exactly like nicotine, very well," Dr. Buccasfusco says. "So we are excited about this possibility."

To explore its antipsychotic potential, he and colleague Dr. Alvin V. Terry Jr., a pharmacist and pharmacologist on the faculty of the University of Georgia and MCG, used a standard model for studying antipsychotic drugs: laboratory rats given schizophrenic-producing drugs that block the natural filtering capabilities of the brain.

Normally rats, or people for that matter, would be startled by a loud noise. But if a less intense noise precedes it, over time, the rodents will be less startled by the second, louder noise. Antipsychotic medications have a similar effect in reducing the startle response.

"Our drug cotinine was nearly as effective as a standard clinically used anti-schizophrenic drug in reversing this response," Dr. Buccafusco said. "This finding holds tremendous promise for patients suffering from schizophrenia since the drugs currently in use are oftentimes associated with severe, long-term neurological side effects, such as parkinsonian-like tremors and memory problems."

Much work remains, including further exploration of how cotinine works and how long it works. Dr. Buccafusco’s lab recently received a transgenic mouse model for Alzheimers’ that develops Alzheimer-like plaques in the brain within the first year of life.

One of his graduate students, Ajay Sood, will use this model for his thesis, studying the neuroprotective potential of cotinine, nicotine and similar drugs in a living disease model. "That is the ultimate test for neuroprotection," Dr. Buccafusco says.

Toni Baker | EurekAlert!
Further information:
http://www.mcg.edu/news/2003NewsRel/cotinine.html

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>